Posttreatment prostate specific antigen nadir predicts prostate cancer specific and all cause mortality.
Journal of Urology.
Times cited: 11
Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size.
International Journal of Radiation Oncology Biology Physics.
Times cited: 9